Clinical Trial Update: This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65. [NA]

View source ↗

Summary

This clinical trial is investigating whether beta-hydroxy-beta-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), administered alone or together, can impro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Sarcopenia

Drugs mentioned

• 2-HOBA (2-hydroxybenzylamine) (2-hydroxybenzylamine)
• HMB (beta-hydroxy-beta-methylbutyrate) (beta-hydroxy-beta-methylbutyrate)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Muscle, Cognitive Functioning | NA | Status: NOT_YET_RECRUITING